Ocugen stock rises 4.05% and outperforms market

8 articles · Updated · MarketWatch · May 1

The shares closed at $1.80 on Friday, extending gains to a third straight session as the S&P 500 rose 0.29% and the Dow Jones fell 0.31%.
Despite the advance, Ocugen remains 33.94% below its 52-week high of $2.73 reached on 17 March.
Trading volume was 3.8 million shares, 5.1 million below the stock's 50-day average of 8.9 million, indicating lighter-than-usual activity.

Analysts see a 441% upside, but short sellers see failure. Who is right about Ocugen's future?

Can Ocugen’s revolutionary gene therapy pipeline outrun its high bankruptcy risk and massive cash burn?